New 24-Strain pneumonia vaccine for kids enters safety testing
NCT ID NCT07300644
Summary
This study is testing a new vaccine designed to protect children from serious infections like pneumonia and meningitis. It will compare the new vaccine's safety and ability to trigger an immune response against an existing, approved vaccine. The trial will involve 420 healthy children aged 2 months to 5 years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qichun District Center for Disease Prevention and Control
RECRUITINGHuanggang, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xian'an District Center for Disease Prevention and Control
RECRUITINGXianning, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangzhou District Center for Disease Prevention and Control
RECRUITINGXiangyang, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.